RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained Health Canada approval for the ORTHO VISION™ Analyzer, a highly interactive, fully automated analyzer for transfusion medicine laboratories. The ORTHO VISION™ Analyzer for ORTHO Column Agglutination Technologies will be commercially available in Canada in the second quarter of 2015.
Although transfusion medicine has evolved to enhance safety and establish critical efficiencies, today’s automation solutions lack the ability to anticipate and respond to individual user needs and ever-changing conditions within the laboratory. The introduction of the ORTHO VISION™ Analyzer represents an advanced system able to meet these needs through automation that is responsive, representing the next evolution in transfusion medicine.
The ORTHO VISION™ Analyzer’s unique pairing of secure monitoring technologies and dynamic work flow management is an advance that offers labs the ability to address unpredictable demands when needed and have confidence in the results.
“With the launch of the ORTHO VISION™ Analyzer and responsive automation, our goal is to greatly improve the safety of blood transfusions by reducing the lab’s reliance on manual methods,” said Alex Socarrás, Executive Vice President, Global Commercial Operations. “We are offering a new solution in Canada that is very much tailored to the blood bank market using efficient and accurate gel technology.”
Designed with secure monitoring technologies for responsive safety checks and balances, the ORTHO VISION™ Analyzer gives transfusion medicine professionals the ability to track critical automated steps in the immunohematology testing process. Through Ortho Clinical Diagnostics’ proprietary Intellicheck® Technology, the ORTHO VISION™ Analyzer verifies and documents diagnostic checks throughout the sampling process; while e-Connectivity® Technology provides 24/7 remote data tracking that monitors and ensures instrument performance while maximizing uptime. Laboratory personnel can also log on anytime, anywhere to collaborate on interpreting results in real time for an extra level of confidence.
In addition to multiple safety advancements, the ORTHO VISION™ Analyzer also delivers dynamic workflow management, providing the adaptability to respond to unpredictable lab demand. Now lab personnel will be able to focus on prioritizing tests as they are requested, including STAT requests, making informed decisions and re-establishing a natural flow in the lab, all while automating more tests than ever before.
Building on its market leadership position, Ortho Clinical Diagnostics is reinforcing its commitment to the transfusion medicine industry with innovations such as the ORTHO VISION™ Analyzer, designed to meet the needs of labs and their patients.
A version of the ORTHO VISION™ Analyzer is commercially available in Europe, Japan and Australia.
About Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. delivers high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit. Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies and automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care. For more information, visit www.orthoclinical.com.
ORTHO VISION™ Analyzer, the ORTHO VISION™ Analyzer logo and Intellicheck® are trademarks of Ortho-Clinical Diagnostics, Inc.